FormFactor's Q3 Earnings Beat Estimates, Revenues Increase Y/Y

FormFactor’s Q3 2026 non-GAAP EPS rose 215.2% year over year to $1.04, beating consensus by 20.93%; revenue increased 38.4% to a record $280.5 million, 3.68% above estimates. Systems revenue grew 63.8% to a record $59.5 million, led by TRITON photonics demand, while reported gross margin reached 56.5%, including about $10.5 million from primarily tariff refunds and favorable component costs. FormFactor forecasts Q4 revenue of $285 million, plus or minus $10 million, and expects 2026 revenue to exceed $1 billion for the first time.

Analysis

The earnings quality is better than the headline EPS growth suggests, but less exceptional than the reported margin implies: roughly $10.5 million of gross-profit support was temporary, leaving underlying gross margin around 52.5–53%. Q4 guidance near 54% therefore matters more than the Q3 beat; it would indicate operating leverage can persist without the one-offs. The structural upside is a second growth engine: optical probing/TRITON broadens FORM beyond conventional probe cards, while the Farmers Branch ramp could let it convert GPU and custom-ASIC design wins into 2027 shipments. The key risk is timing—capacity is not the same as utilization, and co-packaged optics adoption can slip with hyperscaler deployment schedules. DRAM mix also bears watching: a shift toward DDR5 from HBM may support near-term wafer demand but could dilute the most technically intensive testing opportunity.

Contrarian read: investors may over-extrapolate the 215% EPS increase, but could underweight the strategic value of design wins and the potential to raise share as new capacity comes online. Near term, expect the market to focus on normalized margins and Q4 conversion; over 1–3 months, TRITON orders and customer qualification are the key checks. Over 6–18 months, utilization of the new facility and GPU/ASIC share gains determine whether the longer-term operating model is credible. Falsify the bullish view if normalized gross margin falls below the low-50% range, guidance is cut, or capacity ramps without corresponding probe-card revenue growth.

Key Decisions for Investors

• Prefer a staged long in FORM over chasing the headline EPS beat: add on post-results weakness only if the Q4 revenue outlook remains intact and normalized gross margin holds in the low-50% range. Upside is operating leverage plus 2027 design-win conversion; downside is a valuation reset if growth or margins decelerate.
• Treat the Q3 margin beat as partly nonrecurring. Track reported versus underlying gross margin and Q4 results; do not annualize the 56.5% reported margin.
• Use TRITON and GPU/custom-ASIC conversion as alert items, not assumed earnings. Verify order growth, customer qualification, and production utilization before increasing exposure; capacity availability alone is not evidence of demand.
• Reduce or exit the bullish thesis if management lowers the Q4 outlook, underlying gross margin slips below the low-50% range, or the 2027 facility ramp fails to translate into probe-card revenue and share gains.